NCT03817125 2024-06-06MCGRAWParker Institute for Cancer ImmunotherapyPhase 1 Completed14 enrolled 22 charts
NCT01967758 2018-08-17Phase I Study of Safety and Immunogenicity of ADU-623Providence Health & ServicesPhase 1 Completed11 enrolled
NCT01042704 2017-07-31Bendamustine in Combination With Lenalidomide and Dexamethasone in Refractory or Relapsed Multiple MyelomaUniversity of PittsburghPhase 1 Completed29 enrolled